InspireMD, Inc is a medical devices business based in the US. InspireMD shares (NSPR) are listed on the NASDAQ and all prices are listed in US Dollars. InspireMD employs 45 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in InspireMD
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – NSPR – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
InspireMD stock price (NASDAQ: NSPR)Use our graph to track the performance of NSPR stocks over time.
InspireMD shares at a glance
|Latest market close||$5.35|
|52-week range||$4.04 - $22.20|
|50-day moving average||$5.10|
|200-day moving average||$8.50|
|Wall St. target price||$16.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-9.91|
Buy InspireMD shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy InspireMD stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
InspireMD price performance over time
|1 week (2021-07-19)||N/A|
|1 month (2021-06-30)||5.94%|
|3 months (2021-04-30)||-11.13%|
|6 months (2021-01-26)||N/A|
|1 year (2020-07-26)||N/A|
|2 years (2019-07-26)||N/A|
|3 years (2018-07-26)||N/A|
|5 years (2016-07-26)||N/A|
|Revenue TTM||$2.5 million|
|Gross profit TTM||$83,000|
|Return on assets TTM||-25.09%|
|Return on equity TTM||-49.79%|
|Market capitalisation||$36.7 million|
TTM: trailing 12 months
Shorting InspireMD shares
There are currently 85,042 InspireMD shares held short by investors – that's known as InspireMD's "short interest". This figure is 20% down from 106,240 last month.
There are a few different ways that this level of interest in shorting InspireMD shares can be evaluated.
InspireMD's "short interest ratio" (SIR)
InspireMD's "short interest ratio" (SIR) is the quantity of InspireMD shares currently shorted divided by the average quantity of InspireMD shares traded daily (recently around 193277.27272727). InspireMD's SIR currently stands at 0.44. In other words for every 100,000 InspireMD shares traded daily on the market, roughly 440 shares are currently held short.
However InspireMD's short interest can also be evaluated against the total number of InspireMD shares, or, against the total number of tradable InspireMD shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case InspireMD's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 InspireMD shares in existence, roughly 10 shares are currently held short) or 0.0117% of the tradable shares (for every 100,000 tradable InspireMD shares, roughly 12 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against InspireMD.
Find out more about how you can short InspireMD stock.
InspireMD share dividends
We're not expecting InspireMD to pay a dividend over the next 12 months.
Have InspireMD's shares ever split?
InspireMD's shares were split on a 1:15 basis on 26 April 2021. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your InspireMD shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for InspireMD shares which in turn could have impacted InspireMD's share price.
InspireMD share price volatility
Over the last 12 months, InspireMD's shares have ranged in value from as little as $4.04 up to $22.2. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while InspireMD's is 1.84. This would suggest that InspireMD's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
InspireMD, Inc. , a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms and seals the aneurysms. The company sells its products through local distributors. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv, Israel.
InspireMD in the news
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
InspireMD Enrolls and Treats First Patients at Ballad Health System in U.S. Registration C-Guardian Clinical Trial of CGuard EPS
Frequently asked questionsWhat percentage of InspireMD is owned by insiders or institutions?
Currently 2.905% of InspireMD shares are held by insiders and 15.643% by institutions. How many people work for InspireMD?
Latest data suggests 45 work at InspireMD. When does the fiscal year end for InspireMD?
InspireMD's fiscal year ends in December. Where is InspireMD based?
InspireMD's address is: 4 Menorat Hamaor Street, Tel Aviv, Israel, 6744832 What is InspireMD's ISIN number?
InspireMD's international securities identification number is: US45779A8532 What is InspireMD's CUSIP number?
InspireMD's Committee on Uniform Securities Identification Procedures number is: 45779A101
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert